VAL products catalogue has passed the 150 mark. The antibodies are towards key targets within a wide range of organisms for research and clinical applications, all of which are currently available for licensing from Cancer Research Technology at their Ximbio site (https://ximbio.com/organisation/48/vertebrate-antibodies-limited).
